Rockwell (ROK) Form 4: Executive RSU grant and 10b5-1 sales detailed
Rhea-AI Filing Summary
Insider transactions by Cyril Perducat at Rockwell Automation (ROK) show a grant of 581 restricted stock units on 04/09/2025 that convert to common stock and vest in three equal annual installments beginning on the date exercisable. Those 581 RSUs are reported as acquired at $0, increasing his beneficial ownership to 5,222 shares. On 08/29/2025 Perducat sold 1,335 shares at a weighted-average price of $348.0155 and an additional 100 shares at $348.99 under a Rule 10b5-1 plan entered 05/30/2025, reducing his reported beneficial ownership to 3,787 shares. The filer notes availability of share-by-share sale prices upon request.
Positive
- 581 restricted stock units granted with clear vesting in three substantially equal annual installments
- Sales executed under a Rule 10b5-1 plan, providing an affirmative defense and indicating pre-planned disposition
- Disclosure offers additional per-share sale price details on request, showing transparency
Negative
- Reported beneficial ownership decreased from 5,222 to 3,787 shares following the transactions
- 1,435 shares sold on 08/29/2025, representing a reduction in the insider's stake
Insights
TL;DR: Routine executive equity grant and planned sales under a 10b5-1 plan; disclosure aligns with governance norms.
The filing documents a typical restricted stock unit grant and subsequent planned sales executed under a Rule 10b5-1 plan, which provides an affirmative defense against insider trading claims when properly adopted. Vesting occurs in three substantially equal annual installments, which is a common retention structure. The reporting includes weighted-average sale price disclosure and an undertaking to provide per-price detail on request, demonstrating transparency. The transactions materially reduce reported beneficial ownership but are consistent with disclosed plan activity rather than ad hoc sales.
TL;DR: Small-scale insider selling after an RSU grant; not likely material to company valuation.
The reporting person received 581 RSUs exercisable beginning 04/09/2025 and sold 1,435 shares on 08/29/2025 in two tranches at prices around $347.56–$348.99. Beneficial ownership fell from 5,222 to 3,787 shares. The sales occurred under a pre-established 10b5-1 plan entered 05/30/2025, suggesting scheduled disposition rather than information-driven trading. Based solely on the disclosed quantities, the transactions appear minor relative to a large-cap issuer and present limited immediate market impact.